EMERALD MUTUAL FUND ADVISERS TRUST - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$2,835,984
-3.1%
34,2800.0%0.15%
-2.0%
Q1 2024$2,925,798
-68.7%
34,280
-68.6%
0.15%
-69.3%
Q4 2023$9,347,184
-4.8%
109,311
-0.3%
0.50%
-16.5%
Q3 2023$9,821,193
-19.1%
109,636
-23.1%
0.59%
-9.9%
Q2 2023$12,132,620
+2.9%
142,5020.0%0.66%
-5.6%
Q1 2023$11,792,041
+7.4%
142,502
+2.1%
0.70%
+2.5%
Q4 2022$10,981,270
-44.3%
139,622
-47.6%
0.68%
-45.5%
Q3 2022$19,726,000
+7.4%
266,463
-5.5%
1.25%
+17.1%
Q2 2022$18,374,000
+31.1%
281,893
+27.1%
1.06%
+71.8%
Q1 2022$14,020,000
+123.6%
221,768
+216.8%
0.62%
+109.5%
Q2 2020$6,270,000
-73.3%
70,013
-70.3%
0.30%
-79.9%
Q1 2020$23,494,000
-14.5%
235,740
-1.5%
1.47%
+31.2%
Q4 2019$27,489,000
+21.8%
239,240
+33.7%
1.12%
+12.4%
Q3 2019$22,576,000
+12.6%
178,977
+7.4%
1.00%
+25.5%
Q2 2019$20,051,000
+58.2%
166,617
+15.0%
0.80%
+56.7%
Q1 2019$12,678,000
+5.2%
144,927
+20.3%
0.51%
-9.8%
Q4 2018$12,049,000120,4270.56%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders